Eisai and Bristol Myers Squibb Enter Into Global Strategic ...
17 июн. 2021 г. ... Eisai Co., Ltd. and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the companies have entered into an exclusive global ...
Eisai Europe
Our work at Eisai prioritises patients and their families through our focus to continually improve the benefits that health care can provide.
Eisai Co., Ltd.｜A human health care company
Welcome to the Eisai Official Corporate Website Eisai Co., Ltd. Page.
Eisai Reimbursement Resources
Eisai Reimbursement resources, your source for reimbursement information related to select Eisai products.
Eisai US: A research-based pharmaceutical company
Eisai is a research-based human health care company that discovers, develops and markets phamaceutical products internationally. Learn more about Eisai ...
Eisai US | LinkedIn
Eisai US | 118205 followers on LinkedIn. Breaking through in the therapeutic areas of oncology and neurology. View our community guidelines: ...
Eisai to Voluntarily Withdraw BELVIQ®/BELVIQ XR® in the U.S. ...
13 февр. 2020 г. ... However, based on the change in FDA\'s risk-benefit assessment and as requested by the Agency, Eisai has agreed to voluntarily withdraw the ...
Biogen and Eisai amend collaboration agreements on Alzheimer\'s ...
14 мар. 2022 г. ... Biogen and Eisai amend collaboration agreements on Alzheimer\'s disease treatments · Aducanumab collaboration to convert from Eisai sharing of ...
Career Opportunities at EISAI
Nimble and innovative. A cradle of opportunity. Where you\'ll be encouraged to make an immediate impact and challenged to break through. Come collaborate with ...
Eisai Presents Full Results of Lecanemab Phase 3 Confirmatory ...
29 нояб. 2022 г. ... In Eisai\'s confirmatory Clarity AD study, lecanemab demonstrated consistency of results across scales of cognition and function and subgroups ( ...